/PRNewswire/ DelveInsight s Food Allergy Market Insights report proffers a detailed comprehension of Food Allergy market size by treatment, epidemiology,.
- The recent launch of Aimmune's Palforzia has paved the way for other key players to invest in the food allergy treatment market landscape. Further, the FDA-approved fast track designation
Beyond Celiac Outlines Plan to Accelerate a Celiac Disease Cure by 2030
Strategic science plan to change the future for the 3.2 million Americans living with this serious genetic autoimmune disorder
May 13, 2021 10:35 ET | Source: Beyond Celiac Beyond Celiac Ambler, Pennsylvania, UNITED STATES
Philadelphia, PA, May 13, 2021 (GLOBE NEWSWIRE) Beyond Celiac, the leading catalyst for a celiac disease cure in the United States, is celebrating Celiac Awareness Month this month with a laser-focus on its mission to advance the science of celiac disease. Outlined in its strategic science plan developed
under the leadership of Chief Scientist and Strategy Officer Salvatore (Salvo) Alesci, MD, PhD, the organization is committed to addressing the many current barriers to a cure through four scientific priorities: evidence generation, translational research, clinical trials and drug repurposing.
Celiac Disease Foundation Advocates Urge Congress To Continue Support of Celiac Disease Research Funding biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.
Celiac Disease Foundation Advocates Urge Congress To Continue Support of Celiac Disease Research Funding
News provided by
Share this article
Share this article
LOS ANGELES, Feb. 18, 2021 /PRNewswire/ Celiac disease afflicts millions of Americans, most of whom are undiagnosed, and is second only to end-stage renal disease in perceived burden by patients and caregivers. Despite these appalling facts, the federal government has never been a major funder of celiac disease research. As a direct consequence, celiac disease is the most prevalent autoimmune disease with no FDA-approved treatments. For the second consecutive year, the Celiac Disease Foundation will host the
Patient Education & Advocacy Summit, this year on